Mironid Announces Additional Non-Dilutive Funding Through an Early Stage Award from Innovate UK’s Biomedical Catalyst 2016
January 30, 2017
Glasgow, Scotland, 30th January 2017: Mironid® Limited, a leader in cell signalling-directed drug discovery, is delighted to start the New Year by initiating a £606K